9W7P
Crystal Structure of Ledaborbactam in complex with SME-1 class A Carbapenemase
This is a non-PDB format compatible entry.
Summary for 9W7P
| Entry DOI | 10.2210/pdb9w7p/pdb |
| Descriptor | Beta-lactamase SME-1, (3~{R})-2-oxidanyl-3-(propanoylamino)-3,4-dihydro-1,2-benzoxaborinine-8-carboxylic acid, CHLORIDE ION, ... (4 entities in total) |
| Functional Keywords | acyl enzyme complex, carbapenemase, batsa, hydrolase |
| Biological source | Serratia marcescens |
| Total number of polymer chains | 2 |
| Total formula weight | 59333.92 |
| Authors | Dhankhar, K.,Hazra, S. (deposition date: 2025-08-06, release date: 2025-11-19, Last modification date: 2026-03-11) |
| Primary citation | Dhankhar, K.,Hazra, M.,Nair, A.S.R.,Alhmeidi Alkhatib, A.E.,Mishra, N.C.,Hazra, S. Beyond structure and activity: targeting class A carbapenemases with monocyclic and bicyclic boronic acids to counter antimicrobial resistance. Org.Biomol.Chem., 24:1595-1599, 2026 Cited by PubMed Abstract: Bicyclic boronic acids inhibit SME-1 carbapenemase a unique π-π stacking with His105 and covalent interaction with Ser70. Ledaborbactam shows the strongest inhibition, with the lowest and enhanced structural stability. X-ray crystallography and molecular dynamics reveal key features helpful in structure-based optimization of boronates targeting class A β-lactamases. PubMed: 41217385DOI: 10.1039/d5ob01703c PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.2 Å) |
Structure validation
Download full validation report






